Bionik Laboratories Corp. (BNKL)

Market Cap	13.00 -100.0%
Revenue (ttm)	1.81M +41.7%
Net Income	-4.95M
EPS	-0.72
Shares Out	12.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3,268
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0001
Beta	18.79
RSI	38.95
Earnings Date	n/a

About Bionik Laboratories

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Co...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2010
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: BNKL

Financial Performance

In fiscal year 2023, Bionik Laboratories's revenue was $1.81 million, an increase of 41.73% compared to the previous year's $1.27 million. Losses were -$4.95 million, -52.48% less than in 2022.